Paclitaxel is safe and effective in the treatment of advanced AIDS- related Kaposi's sarcoma

Journal of Clinical Oncology

Volumn 17, Issue 6, 1999, Pages 1876-1883

  Gill, Parkash S ^a   Tulpule, Anil ^a   Espina, Byron M ^a   Cabriales, Suzanne ^a   Bresnahan, Jocelyn ^a   Ilaw, Miki ^a   Louie, Stan ^a   Gustafson, Nancy F ^a   Brown, Marilyn A ^a   Orcutt, Christopher ^a   Winograd, Benjamin ^a   Scadden, David T ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL;

ADULT; AIDS RELATED COMPLEX; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HELPER CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT FAILURE; TUMOR REGRESSION;

EID: 0033064114     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.6.1876     Document Type: Article

References (29)

1. Gill PS, Hamilton AW, Naidu Y: Epidemic (AIDS-related) Kaposi's sarcoma: Epidemiology, pathogenesis, and treatment. AIDS Updates 7:1-11, 1994
2. Chachoua A, Krigel R, Lafleur F, et al: Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma. J Clin Oncol 7:774-780, 1989
3. Krown SE, Metroka C, Wernz JC: Kaposi's sarcoma and the acquired immunodeficiency syndrome: A proposal for a uniform evaluation, response and staging criteria. J Clin Oncol 7:1201-1207, 1989
4. Laubenstein LJ, Kriegel RL, Odajnk CM, et al: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115-1120, 1984
5. Mintzer DM, Real FX, Jovino F, et al: Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with acquired immunodeficiency syndrome. Ann Intern Med 102:200-202, 1985
6. Volberding PA, Abrams DI, Conant M, et al: Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 103:335-338, 1985
7. Gelmann EP, Longo D, Lane HC, et al: Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am J Med 82:456-462, 1987
8. Gill PS, Rarick MU, McCutchan JA, et al: Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial. Am J Med 90: 427-433, 1991
9. Bogner JR, Kronawitter U, Rolinski B, et al: Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr 7:463-468, 1994
10. Gill PS, Espina BM, Muggia F, et al: Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 13:996-1003, 1995
11. Gill PS, Wernz J, Scadden DT, et al: Randomized phase III trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi's sarcoma. J Clin Oncol 14:2353-2364, 1996
12. Northfelt DW, Dezube BJ, Thommes JA, et al: Efficacy of pegylated doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J Clin Oncol 15:653-659, 1997
13. Northfelt DW, Dezube BJ, Thommes JA, et al: Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial. J Clin Oncol 16:2445-2451, 1998
14. Stewart S, Jablonski H, Goebel FD, et al: Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol 16:683-691, 1998
15. Rowinsky EK, Cazenave LA, Donehower RC: Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247-1259, 1990
16. Mcquire WP, Rowinsky EK, Rosenshein NB, et al: Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111:273-279, 1989
17. Holmes FA, Walters RS, Theriault RL, et al: Phase II trial of Taxol, an active drug in metastatic breast cancer. J Natl Cancer Inst 83:1979-1805, 1991
18. Saville MW, Lietzau J, Pluda JM, et al: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26-8, 1995
19. Horwitz SB, Cohen D, Rao S, et al: Taxol: Mechanisms of action and resistance. J Natl Cancer Inst Monogr 15:55-62, 1993
20. Klauber N, Parangi S, Flynn E, et al: Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57:81-86, 1997
21. Sikov W, Akerley W, Strenger R, et al: Weekly high dose paclitaxel (P) demonstrates significant activity in advanced breast cancer (BC). Proc Am Soc Clin Oncol 17:112a, 1998 (abstr)
22. Rose WC: Taxol based combination chemotherapy and other in vivo preclinical antitumor studies. J Natl Cancer Inst Monogr 15:47-53, 1993
23. Green S, Weiss GR: Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10:239-253, 1992
24. Kalbfleisch JD, Prentice RL: The statistical analysis of failure time data. New York, NY, John Wiley and Sons, 1980
25. Hryniuk WM, Goodyear M: The calculation of received dose intensity. J Clin Oncol 8:1935-1937, 1990 (editorial)
26. Blum L, Pellet C, Agbalika F, et al: Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable Human Herpes Virus-8 sequences during anti-HIV protease therapy. AIDS 11:1653-1654, 1997
27. Murphy M, Armstrong D, Sepkowitz KA, et al: Regression of AIDS-related Kaposi's sarcoma following treatment with HIV-1 protease inhibitor. AIDS 11:261-262, 1997
28. Volm MD, Wernz J: Patients with advanced AIDS-related Kaposi's sarcoma (EKS) no longer require systemic therapy after introduction of effective anti-retroviral therapy. Proc Am Soc Clin Oncol 16:46a, 1997 (abstr)
29. Welles L, Saville MW, Lietzau J, et al: Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 16:1112-1121, 1989